|
Schizophrenia Spectrum Disorders
Citations 391-400 of 1298 total displayed.
|
Past content
(since Jan 1996):
|
- Letters to the Editor
Aripiprazole and Depression in Schizoaffective Disorder
- JOSEPH R. ERRICO and WILLIAM R. YATES
Am J Psychiatry 2005; 162: 626-a-627-a.
[Full text]
[PDF]
- Letters to the Editor
Memantine and Catatonic Schizophrenia
- CHRISTOPHER THOMAS
Am J Psychiatry 2005; 162: 626.
[Full text]
[PDF]
- Letters to the Editor
Monotherapy Versus Polypharmacy for Hospitalized Psychiatric Patients
- LESLIE CITROME, ARI JAFFE, and JEROME LEVINE
Am J Psychiatry 2005; 162: 631.
[Full text]
[PDF]
- Letters to the Editor
Neurotensin Receptor Agonists and Antagonists for Schizophrenia
- ELLIOTT RICHELSON, PAUL A. FREDRICKSON, and MONA M. BOULES
Am J Psychiatry 2005; 162: 633-b-634-b.
[Full text]
[PDF]
- Letters to the Editor
Neurotensin Receptor Agonists and Antagonists for Schizophrenia
- VIDA B. ROBERTSON and MICHAEL S. WILSON, II
Am J Psychiatry 2005; 162: 634.
[Full text]
[PDF]
- Letters to the Editor
Drs. Meltzer and Arvanitis Reply
- HERBERT Y. MELTZER and LISA ARVANITIS
Am J Psychiatry 2005; 162: 635.
[Full text]
[PDF]
- Articles
Mental Health Service Delivery and Suicide Risk: The Role of Individual Patient and Facility Factors
- Rani A. Desai, David J. Dausey, and Robert A. Rosenheck
Am J Psychiatry 2005; 162: 311-318.
[Abstract]
[Full text]
[PDF]
- Articles
Prevalence and Risk Factors for Homelessness and Utilization of Mental Health Services Among 10,340 Patients With Serious Mental Illness in a Large Public Mental Health System
- David P. Folsom, William Hawthorne, Laurie Lindamer, Todd Gilmer, Anne Bailey, Shahrokh Golshan, Piedad Garcia, Jürgen Unützer, Richard Hough, and Dilip V. Jeste
Am J Psychiatry 2005; 162: 370-376.
[Abstract]
[Full text]
[PDF]
- Brief Reports
Improved P50 Auditory Gating With Ondansetron in Medicated Schizophrenia Patients
- Lawrence E. Adler, Ellen M. Cawthra, Kara A. Donovan, Josette G. Harris, Herbert T. Nagamoto, Ann Olincy, and Merilyne C. Waldo
Am J Psychiatry 2005; 162: 386-388.
[Abstract]
[Full text]
[PDF]
- Brief Reports
Double-Blind, Placebo-Controlled, Multicenter Trial of Selegiline Augmentation of Antipsychotic Medication to Treat Negative Symptoms in Outpatients With Schizophrenia
- J. Alexander Bodkin, Samuel G. Siris, Paul C. Bermanzohn, John Hennen, and Jonathan O. Cole
Am J Psychiatry 2005; 162: 388-390.
[Abstract]
[Full text]
[PDF]
|
|
